These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 12814712

  • 1. Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial.
    Holdaas H, Fellström B, Jardine AG, Holme I, Nyberg G, Fauchald P, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambühl P, Olsson AG, Hartmann A, Solbu DO, Pedersen TR, Assessment of LEscol in Renal Transplantation (ALERT) Study Investigators.
    Lancet; 2003 Jun 14; 361(9374):2024-31. PubMed ID: 12814712
    [Abstract] [Full Text] [Related]

  • 2. Effect of fluvastatin on cardiac outcomes in kidney transplant patients with systemic lupus erythematosus: a randomized placebo-controlled study.
    Norby GE, Holme I, Fellström B, Jardine A, Cole E, Abedini S, Holdaas H, Assessment of Lescol in Renal Transplantation Study Group.
    Arthritis Rheum; 2009 Apr 14; 60(4):1060-4. PubMed ID: 19333947
    [Abstract] [Full Text] [Related]

  • 3. Renal transplant dysfunction--importance quantified in comparison with traditional risk factors for cardiovascular disease and mortality.
    Soveri I, Holdaas H, Jardine A, Gimpelewicz C, Staffler B, Fellström B.
    Nephrol Dial Transplant; 2006 Aug 14; 21(8):2282-9. PubMed ID: 16574686
    [Abstract] [Full Text] [Related]

  • 4. The effect of fluvastatin on cardiac outcomes in patients with moderate to severe renal insufficiency: a pooled analysis of double-blind, randomized trials.
    Holdaas H, Wanner C, Abletshauser C, Gimpelewicz C, Isaacsohn J.
    Int J Cardiol; 2007 Apr 12; 117(1):64-74. PubMed ID: 16889855
    [Abstract] [Full Text] [Related]

  • 5. fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients: post-hoc subgroup analyses of the ALERT Study.
    Jardine AG, Holdaas H, Fellström B, Cole E, Nyberg G, Grönhagen-Riska C, Madsen S, Neumayer HH, Maes B, Ambühl P, Olsson AG, Holme I, Fauchald P, Gimpelwicz C, Pedersen TR, ALERT Study Investigators.
    Am J Transplant; 2004 Jun 12; 4(6):988-95. PubMed ID: 15147434
    [Abstract] [Full Text] [Related]

  • 6. Beneficial effect of early initiation of lipid-lowering therapy following renal transplantation.
    Holdaas H, Fellström B, Jardine AG, Nyberg G, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambühl P, Logan JO, Staffler B, Gimpelewicz C, ALERT Study Group.
    Nephrol Dial Transplant; 2005 May 12; 20(5):974-80. PubMed ID: 15784644
    [Abstract] [Full Text] [Related]

  • 7. Impact of fluvastatin on hyperlipidemia after renal transplantation.
    Tokumoto T, Tanabe K, Ishida H, Shimmura H, Ishikawa N, Goya N, Akiba T, Toma H.
    Transplant Proc; 2004 Sep 12; 36(7):2141-4. PubMed ID: 15518777
    [Abstract] [Full Text] [Related]

  • 8. No detrimental effect on renal function during long-term use of fluvastatin in renal transplant recipients in the Assessment of Lescol in Renal Transplantation (ALERT) study.
    Fellström B, Abedini S, Holdaas H, Jardine AG, Staffler B, Gimpelewicz C, Assessment of Lescol in Renal Transplantation (ALERT) study group.
    Clin Transplant; 2006 Sep 12; 20(6):732-9. PubMed ID: 17100723
    [Abstract] [Full Text] [Related]

  • 9. Effects of fluvastatin on cardiac events in renal transplant patients: ALERT (Assessment of Lescol in Renal Transplantation) study design and baseline data.
    Holdaas H, Fellström B, Holme I, Nyberg G, Fauchald P, Jardine A, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Weinreich T, Olsson AG, Pedersen TR, Benghozi R, Hartmann A, ALERT Study Group. Assessment of Lescol in Renal Transplantation.
    J Cardiovasc Risk; 2001 Apr 12; 8(2):63-71. PubMed ID: 11324372
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of fluvastatin therapy for hypercholesterolemia after heart transplantation: results of a randomised double blind placebo controlled study.
    O'Rourke B, Barbir M, Mitchell AG, Yacoub MH, Banner NR.
    Int J Cardiol; 2004 Apr 12; 94(2-3):235-40. PubMed ID: 15093987
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of fluvastatin on hyperlipidemia after renal transplantation: influence of steroid therapy.
    Austen JL, Shifrin FA, Bartucci MR, Knauss TC, Schulak JA, Hricik DE.
    Ann Pharmacother; 1996 Dec 12; 30(12):1386-9. PubMed ID: 8968448
    [Abstract] [Full Text] [Related]

  • 16. Effect of fluvastatin on lipoprotein profiles in treating renal transplant recipients with dyslipoproteinemia.
    Li PK, Mak TW, Chan TH, Wang A, Lam CW, Lai KN.
    Transplantation; 1995 Oct 15; 60(7):652-6. PubMed ID: 7570971
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of fluvastatin on acute renal allograft rejection: a randomized multicenter trial.
    Holdaas H, Jardine AG, Wheeler DC, Brekke IB, Conlon PJ, Fellstrøm B, Hammad A, Holme I, Isoniemi H, Moore R, Rowe PA, Sweny P, Talbot DA, Wadstrøm J, Østraat Ø.
    Kidney Int; 2001 Nov 15; 60(5):1990-7. PubMed ID: 11703619
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.